Performance of Risk Stratification Tools for Cephalosporin Allergy Testing

This cross-sectional study reports the validity of CEPH-FAST, Urticaria 1-1-1, and Vanderbilt criteria for use in patients with cephalosporin allergy.

Corresponding Authors: Ami P. Belmont, MD, MHS, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208013, New Haven, CT 06520 (ami.belmont@yale.edu); Cosby A. Stone Jr, MD, MPH, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, 1161 21st Ave S, T-1218, MCN, Nashville, TN 37232-2650 (cosby.a.stone@vumc.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.